This story was originally posted on June 14.

Laboratories that would like to use a high-resolution SNP microarray for constitutional and cancer cytogenetics now have more choices.

BlueGnome, the Cambridge, UK-based biotech that Illumina acquired last year, recently added a high-density, Illumina-manufactured SNP chip to its menu of cyto arrays, according to Greg Heath, senior vice president and general manager of Illumina's Diagnostics business.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.